Skip Navigation

Publication Detail

Title: Bile Acids and FXR: Novel Targets for Liver Diseases.

Authors: Stofan, Mary; Guo, Grace L

Published In Front Med (Lausanne), (2020)

Abstract: Bile acids (BAs) are evolutionally conserved molecules synthesized in the liver from cholesterol and have been shown to be essential for lipid homeostasis. BAs regulate a variety of metabolic functions via modulating nuclear and membrane receptors. Farnesoid X receptor (FXR) is the most important nuclear receptor for maintaining BA homeostasis. FXR plays a tissue-specific role in suppressing BA synthesis and promoting BA enterohepatic circulation. Disruption of FXR in mice have been implicated in liver diseases commonly occurring in humans, including cholestasis, non-alcoholic fatty liver diseases, and hepatocellular carcinoma. Strategically targeting FXR activity has been rapidly used to develop novel therapies for the prevention and/or treatment of cholestasis and non-alcoholic steatohepatitis. This review provides an updated literature review on BA homeostasis and FXR modulator development.

PubMed ID: 33015098 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top